+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Contrast Media Market, by Product Type, by Application, by Modality, by Country, Industry Analysis and Forecast, 2019 - 2025

  • ID: 5006173
  • Report
  • February 2020
  • Region: North America
  • 85 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A.
  • Lantheus Holdings, Inc.
  • The Guerbet Group
The North America Contrast Media Market is expected to witness market growth of 2.91% CAGR during the forecast period (2019-2025).

The first contrast agent based on gadolinium had been approved in the United States. Over the past decade, four agents have been licensed in the U.S. and they have set a stringent trend in the industry to continue finding more efficient, reliable, and safe agents. In the coming years, the contrast media revenues are projected to rise in the USA. Sales of contrast media for the ultrasound market might have a significant growth rate among the various imaging modalities. The United States is North America's biggest consumer market for contrast media.

Contrast media is used to enhance the body's internal images created by ultrasound, MRI, x-ray and CT scans. This helps the radiologists to distinguish between normal and abnormal tissues. They're not the dyes that permanently discolor the internal organs. Rather, they are the substances that temporarily change how imaging devices communicate with the body. These help to distinguish the chosen body areas from the surrounding tissue and thus enhance the visibility of different tissues, blood vessels, and organs.

Market growth can be attributed to the oligopolistic existence of the contrast media market. Main companies such as Bayer, GE Healthcare, Guerbet, Lantheus Medical Imaging, and Bracco Diagnostics have a substantial market share for clinical trials. Through indication extension approaches in major countries such as the U.S., these businesses aim for a greater share. They target niche patient cohorts with approvals for unique conditions and raise the degree of product adoption.

Based on Product Type, the market is segmented into Iodinated, Barium-based, Gadolinium-based and Microbubble. Based on Application, the market is segmented into Neurological disorders, Cancer, Cardiovascular disorders, Gastrointestinal disorders, Nephrological disorders, Musculoskeletal disorders and Other Applications. Based on Modality, the market is segmented into X-ray/CT, MRI and Ultrasound. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, General Electric (GE) Co. (GE Healthcare), The Guerbet Group, Lantheus Holdings, Inc., Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., Nano Therapeutics Pvt. Ltd., Magnus Health, LLC (Veracross LLC), Imax Diagnostic Imaging Limited, and Daiichi Sankyo Company, Limited.

Scope of the Study

Market Segmentation:

By Product Type
  • Iodinated
  • Barium-based
  • Gadolinium-based
  • Microbubble

By Application
  • Neurological disorders
  • Cancer
  • Cardiovascular disorders
  • Gastrointestinal disorders
  • Nephrological disorders
  • Musculoskeletal disorders
  • Other Applications

By Modality
  • X-ray/CT
  • MRI
  • Ultrasound

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • Bayer AG
  • General Electric (GE) Co. (GE Healthcare)
  • The Guerbet Group
  • Lantheus Holdings, Inc.
  • Bracco S.p.A.
  • Trivitron Healthcare Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • Magnus Health, LLC (Veracross LLC)
  • Imax Diagnostic Imaging Limited
  • Daiichi Sankyo Company, Limited

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A.
  • Lantheus Holdings, Inc.
  • The Guerbet Group

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Contrast Media Market, by Product Type
1.4.2 North America Contrast Media Market, by Application
1.4.3 North America Contrast Media Market, by Modality
1.4.4 North America Contrast Media Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : Sep, 2019-Mar, 2015) Leading Players
Chapter 4. North America Contrast Media Market by Product Type
4.1 North America Iodinated Market by Country
4.2 North America Barium-based Market by Country
4.3 North America Gadolinium-based Market by Country
4.4 North America Microbubble Market by Country
Chapter 5. North America Contrast Media Market by Application
5.1 North America Neurological disorders Market by Country
5.2 North America Cancer Market by Country
5.3 North America Cardiovascular disorders Market by Country
5.4 North America Gastrointestinal disorders Market by Country
5.5 North America Nephrological disorders Market by Country
5.6 North America Musculoskeletal disorders Market by Country
5.7 North America Other Applications Market by Country
Chapter 6. North America Contrast Media Market by Modality
6.1 North America X-ray/CT Market by Country
6.2 North America MRI Market by Country
6.3 North America Ultrasound Market by Country
Chapter 7. North America Contrast Media Market by Country
7.1 USA Contrast Media Market
7.1.1 USA Contrast Media Market by Product Type
7.1.2 USA Contrast Media Market by Application
7.1.3 USA Contrast Media Market by Modality
7.2 Canada Contrast Media Market
7.2.1 Canada Contrast Media Market by Product Type
7.2.2 Canada Contrast Media Market by Application
7.2.3 Canada Contrast Media Market by Modality
7.3 Mexico Contrast Media Market
7.3.1 Mexico Contrast Media Market by Product Type
7.3.2 Mexico Contrast Media Market by Application
7.3.3 Mexico Contrast Media Market by Modality
7.4 Rest of North America Contrast Media Market
7.4.1 Rest of North America Contrast Media Market by Product Type
7.4.2 Rest of North America Contrast Media Market by Application
7.4.3 Rest of North America Contrast Media Market by Modality
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals:
8.2 General Electric (GE) Co. (GE Healthcare)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 The Guerbet Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Lantheus Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Bracco S.p.A.
8.5.1 Company Overview
8.5.2 Regional Analysis
8.5.3 Recent strategies and developments:
8.5.3.1 Product Launches and Product Expansions:
8.5.3.2 Acquisition and Mergers:
8.5.3.3 Approvals:
8.6 Trivitron Healthcare Pvt. Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Nano Therapeutics Pvt. Ltd.
8.7.1 Company Overview
8.8 Magnus Health, LLC (Veracross LLC)
8.8.1 Company Overview
8.9 Imax Diagnostic Imaging Limited
8.9.1 Company Overview
8.1 Daiichi Sankyo Company, Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
  • Bayer AG
  • General Electric (GE) Co. (GE Healthcare)
  • The Guerbet Group
  • Lantheus Holdings, Inc.
  • Bracco S.p.A.
  • Trivitron Healthcare Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • Magnus Health, LLC (Veracross LLC)
  • Imax Diagnostic Imaging Limited
  • Daiichi Sankyo Company, Limited
Note: Product cover images may vary from those shown

Loading
LOADING...